Generating IP Value Through Corporate Spin-Outs
and Other Creative Deal Structures
October 31, 2018
Thank you to our sponsor:
Program:
Corporations invest billions of dollars in R&D, but not all of the resulting innovation aligns with the corporate strategy. Licensing or selling the resulting IP rights are common ways to generate a return on the R&D investment. However, other creative deal structures such as joint ventures, or spin-outs can sometimes provide significantly higher long-term value and other additional strategic benefits, such as establishing footholds in new markets. Hear about recent transactions that included transfer of IP assets from senior executives.
Panelists:
Stephen Freedman, Vice President for Corporate Liaison and Ventures, Gladstone Institutes – Stephen is Director of the Gladstone Center for Translational Research (GCTR) and Vice President for Corporate Liaison and Ventures at the Gladstone Institutes. Through his leadership, GCTR has facilitated a number of significant strategic relationships and alliances—across all of Gladstone's research areas—with biotech and pharmaceutical companies, venture capital firms and foundations. He has more than 25 years of experience in the pharmaceutical industry, including senior positions at Merck & Co. and Elan Pharmaceuticals.
Maital Rasmussen, Head of Marketing, Roche NAVIFY Diagnostics Information – Maital is a marketing and business development executive with global expertise across a full range of product and corporate marketing functions including marketing strategy, brand messaging and identity, business storytelling and Go-To-Market programs. Maital entered the field with a rapid-growth start-up, and worked her way up to VP at JPMorgan as a Global Marketing Manager and a Senior Relationship Manager as well as a Director of Marketing Strategy at Oracle. At JPMorgan, she established and grew long term relationships with institutional investors, technology companies and the M&A industry which generated $10 million in revenue the first year. At Oracle she established the marketing strategy platform from messaging to go-to-market execution.
Stefan Tamme, VP of IP Strategy & Licensing, Rambus Inc. – Stefan joined Rambus in 2004 leading the strategic development of Rambus’s patent portfolio and the implementation of its IP monetization strategies through its licensing programs and solutions businesses. His responsibilities include outbound licensing and other strategic transactions such as acquisitions and divestitures. He has been involved in negotiating and closing transactions that have generated over $1 billion in revenues for Rambus. Previously, he served as Rambus’s director of global business enablement, where he led the strategic alliance partner program and the worldwide reseller channel. He has over 20 years of technology and licensing experience in the electronics industry, working for start-ups and midsize companies.
Susan Wang, Assistant General Counsel, Pfizer Inc. – Susan is an Assistant General Counsel at Pfizer, where she leads a team of patent attorneys responsible for the patent portfolios and IP strategy for Pfizer’s large molecule oncology assets. Her practice includes patent preparation and prosecution, freedom to operate analyses, landscape studies, patent transactions support, and patent due diligence. Prior to joining Pfizer Susan practiced law at Knobbe Martens. Susan also previously worked as a postdoctoral fellow at Genentech in the department of molecular oncology, and was a law clerk at the United States International Trade Commission Office of Unfair Import Investigations in Washington, D.C. Susan is a graduate of the University of Minnesota Law School, the California Institute of Technology, and University of California, Berkeley.
Moderator: Damon Matteo, CEO, Fulcrum Strategy – Damon provides strategic guidance and tactical execution to realize maximum commercial advantage from innovation and intellectual property assets from invention through monetization. His career spans over 20 years across all facets of the strategic creation, funding, management and commercialization of high-value innovations and IP assets – all in an international context. He has successfully completed transactions representing organizations in the U.S., Europe, and Asia, ranging from Fortune 500® companies to start-ups, universities and national laboratories. Aside from their strategic benefits, a number of these transactions were valued at over US$100 million. Damon operates across industry and technology domains spanning mobile computing & smart-phones, big data, social-networking, energy and clean-tech, web and e-commerce, computer and consumer electronics, networking and telecom.
CLE: 1.5 hours CLE credit available.
